Accord Files Stelara Rival With EMA

Intas Unit Submits Application For Dong-A/Meiji Seika Pharma Ustekinumab Biosimilar

 
• By David Wallace
  
EMA
Intas’s Accord has filed ustekinumab with the EMA

More from Biosimilars

More from Products